Dátum platby dividend spoločnosti NeuroVive Pharmaceutical AB
Aká je hodnota metriky Dátum platby dividend spoločnosti NeuroVive Pharmaceutical AB?
Hodnota metriky Dátum platby dividend spoločnosti NeuroVive Pharmaceutical AB je N/A
Aká je definícia metriky Dátum platby dividend?
Dátum platby dividend (Dividend date) je deň kedy je naplánované vyplatenie dividendov akcionárom.
The dividend date or payment date is the date on which dividends will be paid to shareholders. Only shareholders who owned the stock before an ex-dividend date are entitled to dividends.
Čomu sa venuje spoločnosť NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.